BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18685792)

  • 21. The use of optical techniques to detect conformational changes associated with the interaction of epidermal growth factor and its receptor.
    Waterfield MD; Greenfield C; Hiles I; Federwisch M; Wollmer A; Blundell TL; McDonald N
    Adv Second Messenger Phosphoprotein Res; 1990; 24():301-6. PubMed ID: 2119642
    [No Abstract]   [Full Text] [Related]  

  • 22. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells.
    Perez-Torres M; Valle BL; Maihle NJ; Negron-Vega L; Nieves-Alicea R; Cora EM
    Exp Cell Res; 2008 Oct; 314(16):2907-18. PubMed ID: 18687326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells.
    Kozer N; Henderson C; Jackson JT; Nice EC; Burgess AW; Clayton AH
    Phys Biol; 2011 Dec; 8(6):066002. PubMed ID: 21946082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos.
    Zhao C; Du G; Skowronek K; Frohman MA; Bar-Sagi D
    Nat Cell Biol; 2007 Jun; 9(6):706-12. PubMed ID: 17486115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
    Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
    Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor dimerization monitored in live cells.
    Blakely BT; Rossi FM; Tillotson B; Palmer M; Estelles A; Blau HM
    Nat Biotechnol; 2000 Feb; 18(2):218-22. PubMed ID: 10657132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominance of activated EGFR higher-order oligomers on the cell surface.
    Clayton AH; Orchard SG; Nice EC; Posner RG; Burgess AW
    Growth Factors; 2008 Dec; 26(6):316-24. PubMed ID: 18937111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
    Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
    Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green fluorescent protein as a tool to study epidermal growth factor receptor function.
    Hayes N; Howard-Cofield E; Gullick W
    Cancer Lett; 2004 Apr; 206(2):129-35. PubMed ID: 15013518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational design of an EGF-IL18 fusion protein: implication for developing tumor therapeutics.
    Lu JX; Peng Y; Meng ZF; Jin LQ; Lu YS; Guan MX
    Biochem Biophys Res Commun; 2005 Aug; 334(1):157-61. PubMed ID: 15993840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer.
    Boute N; Pernet K; Issad T
    Mol Pharmacol; 2001 Oct; 60(4):640-5. PubMed ID: 11562424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytoskeletal changes in A-431 cells under the action of epidermal growth factor].
    Skopicheva VI; Skopichev VG; Vinogradova NA; Teslenko LV; Nikol'skiĭ NN
    Tsitologiia; 1991; 33(4):60-4. PubMed ID: 1725073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B; Mayer D
    Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor overexpression or inhibition alters cell surface dynamics of EGF-EGFR interaction: new insights from real-time single molecule analysis.
    Yu C; Hale J; Ritchie K; Prasad NK; Irudayaraj J
    Biochem Biophys Res Commun; 2009 Jan; 378(3):376-82. PubMed ID: 19014905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compartmentalization of epidermal growth factor receptor in liver plasma membrane.
    Wang Y; Posner BI; Balbis A
    J Cell Biochem; 2009 May; 107(1):96-103. PubMed ID: 19288512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
    Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E
    Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulatory role of the juxtamembrane region in the activity of the epidermal growth factor receptor.
    Boran AD
    Biochem Soc Trans; 2012 Feb; 40(1):195-9. PubMed ID: 22260689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
    Lee DH; Szczepanski MJ; Lee YJ
    J Cell Biochem; 2009 Apr; 106(6):1113-22. PubMed ID: 19229860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affibody-mediated retention of the epidermal growth factor receptor in the secretory compartments leads to inhibition of phosphorylation in the kinase domain.
    Vernet E; Lundberg E; Friedman M; Rigamonti N; Klausing S; Nygren PA; Gräslund T
    N Biotechnol; 2009 Sep; 25(6):417-23. PubMed ID: 19552886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.